The Dimerix Limited Clinical Trials – ACTION for Diabetic Kidney Disease and ACTION for Focal Segmental Glomerulosclerosis – Are Now Open!
Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)
Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs
Recent news and media
Dr Nina Webster, CEO of Dimerix, presented to shareholders at the 2018 AGM where she provided a review of key highlights [...]